AnalystsSilvan TuerkcanSilvan Tuerkcan's Stock Forecasts
AnalystsSilvan Tuerkcan
Analyst Ranking
Bottom 4%
#4755 out of 4929 analysts
Average Return
-3.83%
Win Rate
41%71 out of 174
Risk vs Reward
Poor
Good
Silvan Tuerkcan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | +352.88% | $13.35 | $60.46 | 2020-02-28 - 2021-02-26 | Buy |
Logicbio Therapeutics IncLOGC2 | +345.16% | $0.47 | $2.07 | 2022-05-10 - 2022-11-15 | Buy |
Taysha Gene Therapies IncTSHA | +296.41% | $0.72 | $2.87 | 2023-03-30 - 2024-03-28 | Buy |
Benitec Biopharma IncBNTC | +290.63% | $2.88 | $11.25 | 2024-02-15 - 2025-02-14 | Buy |
Benitec Biopharma IncBNTC | +276.14% | $2.85 | $10.72 | 2024-01-24 - 2025-01-23 | Buy |
Silvan Tuerkcan Analyst Color
Get additional color on Silvan Tuerkcan's coverage of popular stocks
Silvan Tuerkcan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crispr Therapeutics AgCRSP | 15 | Buy | $86.00 | +64.85% | Reiterates | 9 days ago |
Nuvation Bio IncNUVB | 3 | Buy | $6.00 | +187.08% | Reiterates | 11 days ago |
Exelixis IncEXEL | 20 | Buy | $50.00 | +8.34% | Maintains | 13 days ago |
Solid Biosciences IncSLDB | 3 | Buy | $15.00 | +198.21% | Reiterates | a month ago |
Taysha Gene Therapies IncTSHA | 13 | Buy | $6.00 | +144.90% | Maintains | a month ago |
Prime Medicine IncPRME | 3 | Buy | $6.00 | +92.93% | Maintains | 2 months ago |
Foghorn Therapeutics IncFHTX | 3 | Buy | $9.00 | +75.44% | Reiterates | 2 months ago |
Benitec Biopharma IncBNTC | 12 | Buy | $20.00 | +51.86% | Reiterates | 2 months ago |
Vor Biopharma IncVOR | 12 | Hold | $6.00 | +214.14% | Downgrades | 2 months ago |
Engene Holdings IncENGN | 4 | Buy | $18.00 | +368.14% | Reiterates | 2 months ago |
Terns Pharmaceuticals IncTERN | 12 | Buy | $20.00 | +362.96% | Reiterates | 2 months ago |
Acrivon Therapeutics IncACRV | 5 | Buy | $17.00 | +1,217.83% | Reiterates | 3 months ago |
Elevation Oncology IncELEV | 7 | Hold | $7.00 | +1,704.12% | Downgrades | 3 months ago |
Jasper Therapeutics IncJSPR | 5 | Buy | $70.00 | +933.97% | Reiterates | 6 months ago |
Context Therapeutics IncCNTX | 1 | Buy | $4.00 | +525.00% | Initiates Coverage On | 6 months ago |
Relay Therapeutics IncRLAY | 10 | Buy | $21.00 | +478.51% | Reiterates | 7 months ago |
Macrogenics IncMGNX | 10 | Buy | $8.00 | +447.95% | Maintains | a year ago |
Cellectis SaCLLS | 6 | Buy | $6.00 | N/A | Reiterates | a year ago |
Notable Labs LtdNTBLQ | 3 | Buy | $9.00 | N/A | Reiterates | a year ago |
Mondaycom LtdMNDY | 3 | Buy | $280.00 | N/A | Maintains | a year ago |
Mirati Therapeutics IncMRTX | 8 | Buy | $82.00 | N/A | Maintains | 2 years ago |
Generation Bio CoGBIO | 6 | Buy | $7.00 | N/A | Reiterates | 2 years ago |
Two Harbors Investment CorpTWO | 1 | Buy | $18.00 | N/A | Maintains | 2 years ago |
Intellia Therapeutics IncNTLA | 7 | Buy | $111.00 | N/A | Maintains | 3 years ago |
Logicbio Therapeutics IncLOGC2 | 3 | Buy | $3.00 | N/A | Maintains | 3 years ago |
Turning Point Therapeutics IncTPTX | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Seagen IncSGEN | 2 | Buy | $200.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.